Author(s): Kamlesh Patel, Rajendra Chouksey

Email(s): kammu.patel@gmail.com

DOI: 10.52711/0975-4377.2023.00007   

Address: Kamlesh Patel, Rajendra Chouksey
Patel College of Pharmacy, Madhyanchal Professional University, Ratibad - 462044, Bhopal, Madhya Pradesh.
*Corresponding Author

Published In:   Volume - 15,      Issue - 1,     Year - 2023


ABSTRACT:
In recent years, gastro-retentive drug delivery system (GRDDS) has gained researcher’s interest in the field of oral drug delivery. Various GRDDS approaches can be utilized to retain the dosage forms in the stomach and to release the drug slowly for an extended period of time. GRDDS can be used to prolong the residence time of delivery system in the stomach. This results in targeting of drug release at a specific site for the systemic or local effects. GRDDS can be used to overcome challenges associated with conventional oral dosage forms and to release the drug at a specific absorption site to improve bioavailability of particular drug substance. The challenges include fast gastric emptying of the dosage form which results in the poor bioavailability of the drug. Prolongation of the retention of drugs in stomach those having low solubility at high intestinal pH improves the solubility of drugs. GRDDS has proved to be effective in systemic actions as well as in local actions to treat gastric or duodenal ulcers. Local activity in the upper part of the small intestine can be obtained by improving the residence time of delivery system in the stomach. The system is useful for drugs which are unstable in the intestine or having a low solubility/permeability in the small intestine. Various GRDDS approaches include high density (sinking) systems, low-density (floating systems), muco-adhesive, expandable, unfold able, super porous hydrogel systems, and magnetic systems.


Cite this article:
Kamlesh Patel, Rajendra Chouksey. A Recent Advantage on Gastroretentive Drug Delivery System: An Overview. Research Journal of Pharmaceutical Dosage Forms and Technology.2023; 15(1):36-4. doi: 10.52711/0975-4377.2023.00007

Cite(Electronic):
Kamlesh Patel, Rajendra Chouksey. A Recent Advantage on Gastroretentive Drug Delivery System: An Overview. Research Journal of Pharmaceutical Dosage Forms and Technology.2023; 15(1):36-4. doi: 10.52711/0975-4377.2023.00007   Available on: https://rjpdft.com/AbstractView.aspx?PID=2023-15-1-7


REFERENCES:
1.    Misra A, Singh B. Gastroretentive drug delivery systems. In: In Vitro in Vivo Tools Drug Delivery Research for Optimum Clinical Outcomes. United Kingdom: Taylor & Francis Group; 2018. p. 173-208.
2.    Kesarla RS, Vora PA, Sridhar BK, Patel G, Omri A. Formulation and evaluation of floating tablet of H2-receptor antagonist. Drug Dev Ind Pharm 2015; 41:1499-511.
3.    Prinderre P, Sauzet C, Fuxen C. Advances in gastro retentive drug-delivery systems. Expert Opin Drug Deliv 2011; 8:1189-203.
4.    Aoki H, Iwao Y, Mizoguchi M, Noguchi S, Itai S. Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication. Eur J Pharm Biopharm 2015; 92:22-7.
5.    Kim JY, Bae HJ, Choi J, Lim JR, Kim SW, Lee SH, et al. Efficacy of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats. Arch Pharm Res 2014; 37:1053-62.
6.    Garg R, Gupta G. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008; 7:1055-66.
7.    Matharu RS, Sanghavi NM. Novel drug delivery system for captopril. Drug Dev Ind Pharm 1992; 18:1567-74.
8.    Rouge N, Allémann E, Gex-Fabry M, Balant L, Cole ET, Buri P, et al. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helv 1998; 73:81-7.
9.    Sharma S, Pawar A. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 2006; 313:150-8.
10.    Goole J, Vanderbist F, Amighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm 2007; 334:35-41.
11.    Santus G, Lazzarini C, Bottoni G, Sandefer EP, Page RC, Doll WJ, et al. An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm 1997; 44:39-52.
12.    Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Release 2003; 90:143-62.
13.    Park K. Enzyme-digestible swelling hydrogels as platforms for long-term oral drug delivery: Synthesis and characterization. Biomaterials 1988; 9:435-41.
14.    Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release 2013; 168:151-65.
15.    Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS PharmSciTech 2005; 6:372-90.
16.    Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Deliv 2011; 18:97-110.
17.    Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 2006;6:501-8.
18.    Laulicht B, Tripathi A, Schlageter V, Kucera P, Mathiowitz E. Understanding gastric forces calculated from high-resolution pill tracking. Proc Natl Acad Sci U S A 2010; 107:8201-6.
19.    Talukder R, Fassihi R. Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm 2004; 30:1019-28.
20.    Minami H, Mccallum RW. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 1984; 86:1592-610.
21.    Mandal UK, Chatterjee B, Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian J Pharm Sci 2016; 11:575-84.
22.    Wilson C, Washington N, Washington C, Physiological Pharmaceutics: Barriers to Drug Absorption. United States: CRC Press; 2000.
23.    O’Reilly S, Wilson CG, Hardy JG. The influence of food on the gastric emptying of multiparticulate dosage forms. Int J Pharm 1987; 34:213-6.
24.    Khosla R, Feely LC, Davis SS. Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int J Pharm 1989; 53:107-17.
25.    Khosla R, Davis SS. The effect of tablet size on the gastric emptying of non-disintegrating tablets. Int J Pharm 1990;62:R9
26.    Timmermans J, Moës AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. J Pharm Sci 1994; 83:18-24.
27.    Bennett CE, Hardy JG, Wilson CG. The influence of posture on the gastric emptying of antacids. Int J Pharm 1984; 21:341-7.
28.    Coupe AJ, Davis SS, Evans DF, Wilding IR. Nocturnal scintigraphic imaging to investigate the gastrointestinal transit of dosage forms. J Control Release 1992; 20:155-62.
29.    Nimmo J, Heading RC, Tothil P, Prescott LF. Pharmacological modification of gastric emptying: Effects of propantheline and metoclopromide on paracetamol absorption. Br Med J 1973; 1:587-9.
30.    Umamaheshwari RB, Ramteke S, Jain NK. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model. AAPS PharmSciTech 2004; 5:60-8.
31.    Lopes CM, Bettencourt C, Rossi A, Buttini F, Barata P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm 2016; 510:144-58.
32.    El-Zahaby SA, Kassem AA, El-Kamel AH. Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori. Saudi Pharm J 2014; 22:570-9.
33.    Cvijic S, Ibric S, Parojcic J, Djuris J. An in vitro-in silico approach for the formulation and characterization of ranitidine gastroretentive delivery systems. J Drug Deliv Sci Technol 2018; 45:1-10.
34.    Diós P, Nagy S, Pál S, Pernecker T, Kocsis B, Budán F, et al. Preformulation studies and optimization of sodium alginate based floating drug delivery system for eradication of Helicobacter pylori. Eur J Pharm Biopharm 2015; 96:196-206.
35.    Fu J, Yin H, Yu X, Xie C, Jiang H, Jin Y, et al. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. Int J Pharm 2018; 549:370-9.
36.    Kagan L, Lapidot N, Afargan M, Kirmayer D, Moor E, Mardor Y, et al. Gastroretentive accordion pill: Enhancement of riboflavin bioavailability in humans. J Control Release 2006; 113:208-15.
37.    Sarkar D, Nandi G, Changder A, Hudati P, Sarkar S, Ghosh LK. Sustained release gastroretentive tablet of metformin hydrochloride based on poly (acrylic acid)-grafted-gellan. Int J Biol Macromol 2017;96:137-48.
38.    Thapa P, Jeong SH. Effects of formulation and process variables on gastroretentive floating tablets with a high-dose soluble drug and experimental design approach. Pharmaceutics 2018; 10:9-12.
39.    Oh TO, Kim JY, Ha JM, Chi SC, Rhee YS, Park CW, et al. Preparation of highly porous gastroretentive metformin tablets using a sublimation method. Eur J Pharm Biopharm 2013; 83:460-7.
40.    He W, Li Y, Zhang R, Wu Z, Yin L. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: Preparation and in vitro/in vivo evaluation. Int J Pharm 2014; 476:223-31.
41.    Hwang KM, Cho CH, Tung NT, Kim JY, Rhee YS, Park ES. Release kinetics of highly porous floating tablets containing cilostazol. Eur J Pharm Biopharm 2017;115:39-51.
42.    Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y, et al. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation. Int J Pharm 2018; 545:37-44.
43.    Sawicki W. Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. Eur J Pharm Biopharm 2002;53:29-35.
44.    Jiménez-Martínez I, Quirino-Barreda T, Villafuerte-Robles L. Sustained delivery of captopril from floating matrix tablets. Int J Pharm 2008; 362:37-43.
45.    Sharma AR, Khan A. Gastro-retentive drug delivery system: an approach to enhance gastric retention for prolonged drug release. Indian J Pharm Sci. 2014; 5:1095.
46.    Gupta P, Kesh M. Formulation and evaluation of gastro-retentive floating tablets. Int J Pharm 2018; 6:1.
47.    Pandey A, Kumar G, Kothiya P, Brasilia Y. A review of current approaches in the gastro retentive drug delivery system. Asian J Pharm Health Sci 2012; 2:139-46.
48.    Sandhya P, Farhat A, Benaziya F, Durani HZ. A review of the gastro retentive drug delivery system of helicobacter pylori. Int J Pharma Res Rev 2013; 1:403.
49.    Rathod HJ, Mehta DP, Yadav JS. A review on gastroretentive drug delivery systems. Pharma Tutor 2016; 4:29-40. Res Rev 2013; 1:403.
50.    Badoni A, Ojha A, Gnanarajan G, Kothiyal P. Review on gastro retentive drug delivery system. Pharma Tutor 2016; 4:29-40.
51.    Makwana A, Sameja K, Parekh H, Pandya Y. Advancements in controlled release gastroretentive drug delivery system: a review. Pharma Innov 2012;1(8, Part A):32.
52.    Nayak KP, Upadhyay P, Valera AR, Chauhan NP. Gastroretentive drug delivery systems and recent approaches: a. J Pharm ResOpinion 2012;2:1-8.
53.    Kagan L, Hoffman A. Selection of drug candidates for gastroretentive dosage forms: pharmacokinetics following continuous intragastric mode of administration in a rat model.Eur J Pharm Biopharm 2008;69:238-46.
54.    Reddy LH, Murthy RS. Floating dosage systems in drug delivery. Crit Rev TherDrug Carrier
55.    Hoffman A. Pharmacodynamic aspects of sustained-release preparations. Adv Syst 2002; 19:553-85. Drug
56.    Huang Y, Leobandung W, Foss A, Peppas NA. Molecular aspects of muco-and bioadhesion: tethered structures and site-specific surfaces. J Controlled Delivery Rev 1998; 33:185-99.
57.    Hooda A, Nanda A, Jain M Kumar, Rathee P. Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software. Int J Biol Macromol 2012;51:691-700.2000;65:63-71.
58.    Pawar HA, Dhavale R. Development, and evaluation of gastroretentive floating tablets of an antidepressant drug by thermoplastic granulation technique. Beni-Suef University J Basic Appl Sci 2014; 3:122-32.
59.    Vyas SP, Khar RK. Gastro retentive system in controlled drug delivery: concepts and advances. Nayal AS, Pandey S, Gnanarajan G. Review: an overview on gastro retentive floating tablet. Int J Pharm Chem Sci 2013; 2:1357-65.
60.    Sravya K, Kavitha K, Rupeshr M, Jagdeesh Singh.Gastroretentive drug delivery systems: a review. Res J Pharm Biol Chem Sci 2012; 3:966-80.
61.    Machete H, Patel MR, Patel KR, Patel MS. An overview of floating drug delivery system. Pharma Tutor 2014; 2:61-71.
62.    Jamil F, Kumar S, Sharma S, Vishwakarma PS, Singh L. Review on stomach specific drug delivery systems: development and evaluation. Int J Res Pharm Biomed Sci 2011; 2:142-71433.
63.    Patel N, Nagesh C, Chandrashekhar S, Jinal P, Devdatt J. Floating drug delivery system: an acceptable innovative approach in gastroretentive drug delivery. Res J Pharm Dosage Forms Technol 2012;4:93-103.
64.    Makwana A, Sameja K, Parekh H, Pandya Y. Advancements in controlled release gastroretentive drug delivery system: a review. J Drug Delivery Ther 2012; 2:44-5.
65.    Pilgaonkar PS, Rustomjee MT, Gandhi AS. Inventors; Rubicon Res Pvt Ltd, assignee. Gastroretentive dosage forms of GABA analogs. U. S patent application, US 13/700,794; 2013.
66.    Chawla G, Bansal A. A means to address regional variability in intestinal drug absorption. Pharm Tech 2003;27:50-68.
67.    Sheth PR, Tossounian J. The hydrodynamically balanced system (HBS™): a novel drug delivery system for oral use. Drug Dev Ind Pharm 1984;10:313.
68.    Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech 2005;6:372-90.
69.    Prakash B, Neelima K, Snehith S, Ramesh C. Development of gastroretentive drug delivery system. ARSPharmaceutica
70.    Watts J, Smith A, Bond J, Lafferty W. Floating drug delivery composition. WO/2001/058424; 2001. 2009;5:8-24.
71.    Vyas SP, Khar RK. Gastroretentive systems. In: Controlled drug Delivery. Vallabh Prakashan. Delhi, India; 2006. p. 197-217.
72.    Clarke GM, Newton JM, Short MD. Gastrointestinal transit of pellets of differing size and density. Int J Pharm 1993;100:81-92.
73.    Moes AJ. Gastric retention systems for oral drug delivery. Business Briefing: Pharmatech; 2003. p. 157-9.
74.    Vedha Hari BN. The recent developments on gastric floating drug delivery systems: an overview. Int J Pharmtech Res2010;2:524-34.
75.    Rednick AB, Tucker SJ. Sustained-release bolus for animal husbandry, US patent US; 1970;3: 507-952.
76.    Geetha A, Kumar J Rajendra, Mohan CH Krishna. Review on: floating drug delivery systems. Int J Pharm Res Biomed Anal 2012;1:1-13.
77.    Choi BY, Park HJ, Hwang SJ, Park JB. Preparation of alginate beads for floating drug delivery system effects of CO2
78.    Ichikawam, Watenables, Miyake Y. A multiple-unit oral floating dosage systems preparation and in vivo evaluation of floating and sustained-release characteristics. J Pharm Sci 1991;80:1062-6. Gas-forming agents. Int J Pharm 2002; 239:81-91.
79.    Sriamornsak P, Thirawong N, Puttipipatkhachorn S. Emulsion gel beads of calcium pectinate capable of floating on the gastric fluid: effect of some additives, hardening agent or coating on release behavior of metronidazole. Eur J Pharm Sci 2005; 24: 363-73.
80.    Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder. Int J Pharm 2002; 241: 279-92.
81.    Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci 2003; 18: 37-45.
82.    Sato Y, Kawashima Y, Takenchi H, Yamamoto H. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2003; 55: 297-304.
83.    Talukdar R, Fassihi R. Gastroretentive delivery systems: hollow beads. Drug Dev Ind Pharm 2004; 30: 405-12.
84.    Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained release floating dosage form of amoxicillin trihydrate. Int J Pharm 1992; 86: 79-88.
85.    Seth PR, Tossounian J. The hydrodynamically balanced system, a novel drug delivery system for oral use. Drug Dev Ind Pharm 1984; 10: 313-39.
86.    Hwang SJ, Park H, Park K. Gastroretentive delivery systems. Crit Rev Ther Drug Carrier Syst 1998; 15(3): 243-84.
87.    Reddy LH, Murthy RS. Floating dosage system in drug delivery. Crit Rev Ther Drug Carrier Syst 2002; 19(6): 553-85.
88.    Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F. Gastroretentive dosage forms: overview and special case of Helicibacter pylori. J Control Release 2006; 111: 1-18.
89.    Kawashima Y, Niwa T, Takenchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992; 81: 135- 40.
90.    Whiteland L, Fell JT, Collett JH. Development of gastroretentive dosage form. Eur J Pharm Sci 1996; 4(suppl.): S182.
91.    Harrigan RM. Drug delivery device for preventing contact of undissolved drug with the stomach lining. US Patent 405 5178; October 25, 1977.
92.    Ingani HM, Timmermans J, Moes A. Conception and in vivo investigation of per oral sustained release floating dosage forms with enhanced gastrointestinal transit. Int J Pharm 1987; 35(12): 157-64.
93.    Krogel I, Bodmeir R. Floating or pulsatile drug delivery system based on coated effervescent cores. Int J Pharm 1999; 187(2): 175-84.
94.    Moes A. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993; 10: 143-95.

Recomonded Articles:

Author(s): Swapnil T. Deshpande, P. S. Vishwe, Rohit D. Shah, Swati S. Korabu, Bhakti R. Chorghe, DG Baheti

DOI:         Access: Open Access Read More

Author(s): Dipti G. Phadtare, Amol R. Pawar, R.B. Saudagar, Govind K.Patil

DOI: 10.5958/0975-4377.2017.00002.7         Access: Open Access Read More

Author(s): Chirag A. Patel, Priyal R. Patel, Dhrubo Jyoti Sen,Jayvadan K. Patel

DOI:         Access: Open Access Read More

Author(s): Kritika Kanoujia, Chandraprabha Dewangan, Ayushi Masih, Dipti Sinha, Divya Oraon, Manisha Jaiswal, Monika Sahu, Ranjeeta Kumari, Sapna Pradhan, Ravi Suman, Rajkishan Dewangan, Roman Banjare, Pradeep Paikra, Mukesh Rawtiya, Mukta Agrawal, Ajazuddin, D. K. Tripathi, Amit Alexander

DOI: 10.5958/0975-4377.2018.00015.0         Access: Open Access Read More

Author(s): Patil Namrata D., Gondkar S.B., Saudagar R.B.

DOI: 10.5958/0975-4377.2016.00033.1         Access: Open Access Read More

Author(s): Hardik B. Rana, Kajol Patel, Mansi Dholakia, Vaishali T. Thakkar, Mukesh C. Gohel, Tejal R. Gandhi

DOI: 10.5958/0975-4377.2017.00006.4         Access: Open Access Read More

Author(s): Ashok Thulluru, K. Saravanakumar, Ch. S. Phani Kumar, Nawaz Mahammed, D. Sreeja, G. Bhuvanesh, N. Vamsi Chowdary, Nayeema Khowser Shaik

DOI: 10.5958/0975-4377.2019.00049.1         Access: Open Access Read More

Author(s): Varsha R. Sandhan, S.B. Gondkar, R. B. Saudagar

DOI:         Access: Open Access Read More

Author(s): Suresh A. Marnoor

DOI:         Access: Open Access Read More

Author(s): Doppalapudi Sandeep, A. P. Pratyusha, G. Sudheshna, K. Lakshmi prasanna, P. Sreekanth

DOI:         Access: Open Access Read More

Author(s): Masheer Ahmed Khan

DOI:         Access: Open Access Read More

Author(s): Shoaib Ahmad

DOI: 10.5958/0975-4377.2016.00041.0         Access: Open Access Read More

Author(s): V. Saikishore, G. Srikanth, Ch. Pooja, Y. Mrudula, R. Pavani, Ch. Jyosthna , C. Mayuren

DOI:         Access: Open Access Read More

Author(s): Patel Chirag J., Asija Sangeeta, Patel Pinkesh, Mangukia Dhruv, Satyanand Tyagi

DOI:         Access: Open Access Read More

Author(s): Swati Rawat, Shradha Sangali, Akhilesh Gupta

DOI: 10.5958/0975-4377.2018.00001.0         Access: Open Access Read More

Author(s): Nakkala Balaji , V. Sai Kishore , Kasani Hari Krishna Gouda

DOI:         Access: Open Access Read More

Author(s): Abhijit Chormale, Dharmendra Mundhada, Rajesh Mujoriya

DOI: 10.5958/0975-4377.2015.00026.9         Access: Open Access Read More

Research Journal of Pharmaceutical Dosage Forms and Technology (RJPDFT) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. ...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0975-4377 


Recent Articles




Tags